Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene Symbol | B2M | ||||||||||
Synonyms | AMYLD6 | IMD43 | MHC1D4 | ||||||||||
Gene Description | B2M, beta-2-microglobulin, forms the light chain of the class I major histocompatibility complex (MHC) (PMID: 3312414) and is required for antigen presentation during the immune response (PMID: 27433843). B2M loss of function mutations have been associated with mismatch repair (MMR) deficiency in colon cancer (PMID: 28616688) and with acquired resistance to immune checkpoint inhibitors in melanoma (PMID: 27433843, PMID: 30466478). | ||||||||||
|
Variant | Impact | Protein Effect | Variant Description | Associated With Drug Resistance |
---|
Variant | Impact | Protein Effect | Variant Description | Associated With Drug Resistance |
---|
Molecular Profile | Protein Effect | Treatment Approaches |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|